CANDRIAM S.C.A. – Karuna Therapeutics, Inc. Transaction History
CANDRIAM S.C.A. portfolio value:
$18.49M
portfolio value
CANDRIAM S.C.A. quarter portfolio value change:
+77.80%
quarter
Karuna Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -7.36% | -6.52K shares | 7.26M | $224.93 | 82.20K |
| Q2 2022 | share | Increase | +42.89% | 26.63K shares | 3.35M | $126.51 | 88.72K |
| Q1 2022 | share | Increase | +225.86% | 43.03K shares | 5.37M | $126.79 | 62.09K |
| Q4 2021 | share | Decrease | -65.19% | -35.69K shares | -4.20M | $130.08 | 19.05K |
| Q3 2021 | share | 0.00% | 0 shares | 456K | $122.33 | 54.75K | |
| Q2 2021 | share | Increase | 0.00% | 54.75K shares | 6.24M | $113.99 | 54.75K |